Talon Resources Targets Ontario Gold Growth After AIM Move and Eagle Lake Acquisition, CEO Says.Watch here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBodycote Regulatory News (BOY)

Share Price Information for Bodycote (BOY)

Share Price is delayed by 15 minutes
Get Live Data
681.50    -11.50 (-1.66%)
Bid:
681.00
Ask:
681.50
Spread: 0.50 (0.073%)
Market Cap: £1.16b
BOY Live PriceLast checked at - London Stock Exchange

Intraday Bodycote Share Chart

Long-term incentive performance measures and targets

17 Apr 2025 15:43

Bodycote Plc - Long-term incentive performance measures and targets

Bodycote Plc - Long-term incentive performance measures and targets

PR Newswire

LONDON, United Kingdom, April 17

17 April 2025

Bodycote plc

(the Company) Β 

Long-term Incentive Performance Measures and Targets

Β 

Further to the publication of the 2024 Annual Report and Accounts on 15 April 2025 (RIS ref: 4136167), the Company confirms that the performance targets to be used for the Bodycote Incentive Plan (BIP) award made on 21 March 2025 (as referenced in the Directors’ remuneration report) are as set out below:

MetricΒ 

EPS level below which no award vests

Threshold

(25% vesting)

Target

(100% vesting)

Maximum

(175% vesting)

Return on Capital

Employed (ROCE)1

(40%)

47p

15.0%

17.2%

20.0%

Earnings Per Share (EPS) CAGR

(40%)

-

+2%

+ 5%

+10%

ESG2 (absolute Group CO2e emissions)

(20%)

Β 

-

Maximum of 243.1ktCO2e

(a reduction over three years of at least 7.3%)

Β 

Maximum of 228.2ktCO2e

(a reduction over three years of at least 13.0%)

Β 

1 For the purposes of the BIP, pre-tax ROCE is calculated using actual exchange rates. Capital Employed includes the goodwill existing as at the start of the performance period (1 January 2025) only.

2 Full vesting of the EPS metric will be based on meeting the Group’s new SBTi target reduction, requiring absolute reductions by December 2027 to align to the Group’s 2030 target (a 46% reduction compared with 2019 levels). This equates to an average annual reduction of 4.5%. The threshold target will be based on meeting an annual absolute reduction that aligns with a β€˜well-below 2 degree’ pathway, which requires an average annual reduction of 2.5%.

Β Β 

For further information, please contact:

Bodycote plc

Jim Fairbairn, Chief Executive Officer

Ben Fidler, Chief Financial Officer

Peter Lapthorn, Head of FP&A and Investor Relations

Tel: +44 1625 505300

Β 

FTI Consulting

Richard Mountain

Susanne Yule

Tel: +44 20 3727 1340

Β 



Date   Source Headline
22nd Jun 20264:19 pmPRNHolding(s) in Company
22nd Jun 20267:00 amPRNTransaction in Own Shares
18th Jun 20263:23 pmPRNHolding(s) in Company
17th Jun 20264:21 pmPRNHolding(s) in Company
17th Jun 202612:31 pmPRNHolding(s) in Company
16th Jun 20262:47 pmPRNHolding(s) in Company
15th Jun 20267:00 amPRNTransaction in Own Shares
8th Jun 20263:20 pmRNSForm 8.3 - Bodycote plc
8th Jun 20262:27 pmRNSForm 8.3 - Bodycote Plc
8th Jun 202611:53 amRNSForm 8.5 (EPT/NON-RI) - BODYCOTE PLC
8th Jun 202611:45 amGNWMan Group PLC : Form 8.3 - Bodycote Plc
8th Jun 202611:45 amBUSMan Group PLC : Form 8.3 - Bodycote Plc
8th Jun 202611:37 amRNSForm 8.5 (EPT/NON-RI) - Bodycote plc
8th Jun 202611:33 amRNSForm 8.5 (EPT/NON-RI)-Bodycote plc
8th Jun 202611:30 amRNSForm 8.5 (EPT/RI) - Bodycote PLC
8th Jun 202611:21 amRNSForm 8.5 (EPT/RI)-Bodycote plc
8th Jun 202611:01 amRNSForm 8.5 EPT/Non RI BODYCOTE PLC
8th Jun 20267:00 amRNSForm 8.3 - Bodycote
8th Jun 20267:00 amPRNTransaction in Own Shares
5th Jun 20263:22 pmRNSForm 8.3 - Bodycote plc
5th Jun 20263:20 pmRNSForm 8.3 - Bodycote plc
5th Jun 20262:45 pmRNSForm 8.3 - Bodycote plc
5th Jun 20262:44 pmRNSForm 8.3 - Bodycote plc
5th Jun 20262:31 pmRNSForm 8.3 - Bodycote plc
5th Jun 20261:48 pmRNSForm 8.3 - Bodycote plc
5th Jun 20261:34 pmRNSForm 8.3 - Bodycote PLC
5th Jun 202611:58 amRNSForm 8.5 (EPT/NON-RI) - BODYCOTE PLC
5th Jun 202611:55 amRNSForm 8.5 (EPT/RI) - BODYCOTE PLC
5th Jun 202611:30 amRNSForm 8.5 (EPT/RI)-Bodycote plc
5th Jun 202611:18 amRNSForm 8.5 (EPT/NON-RI)-Bodycote plc
5th Jun 20269:49 amRNSForm 8.5 (EPT/NON-RI) Bodycote Plc
5th Jun 20269:21 amRNSForm 8.5 EPT/Non RI BODYCOTE PLC
5th Jun 20267:45 amRNSDisclosure Table
5th Jun 20267:04 amPRNResponse to statement by Apollo
5th Jun 20267:00 amRNSRule 2.8 Announcement
4th Jun 20263:20 pmRNSForm 8.3 - Bodycote plc
4th Jun 20262:49 pmRNSForm 8.3 - Bodycote plc
4th Jun 20262:47 pmRNSForm 8.3 Bodycote plc
4th Jun 20262:44 pmRNSForm 8.5 (EPT/NON-RI) - BODYCOTE PLC
4th Jun 20262:38 pmEQSForm 8.3 - The Vanguard Group, Inc.: Bodycote plc
4th Jun 202611:54 amRNSForm 8.5 (EPT/RI) - BODYCOTE PLC
4th Jun 202611:45 amRNSForm 8.5 EPT/Non RI BODYCOTE PLC
4th Jun 202611:22 amRNSForm 8.5 (EPT/NON-RI)-Bodycote plc
4th Jun 202611:09 amRNSForm 8.5 (EPT/RI)-Bodycote plc
4th Jun 202610:29 amRNSForm 8.5 (EPT/NON-RI) Bodycote Plc
3rd Jun 20263:20 pmRNSForm 8.3 - Bodycote plc
3rd Jun 20263:05 pmRNSForm 8.3 - Bodycote plc
3rd Jun 20262:24 pmRNSForm 8.5 (EPT/NON-RI) - BODYCOTE PLC
3rd Jun 20262:00 pmRNSForm 8.3 - Bodycote Plc
3rd Jun 20261:46 pmEQSForm 8.3 - The Vanguard Group, Inc.: Bodycote plc

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.